Professional
Added to YB: 2025-09-26
Pitch date: 2025-06-30
BDX [neutral]
Becton, Dickinson and Company
+17.93%
current return
Author Info
No bio for this author
Company Info
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Market Cap
$56.6B
Pitch Price
$170.35
Price Target
N/A
Dividend
2.12%
EV/EBITDA
11.84
P/E
34.09
EV/Sales
3.48
Sector
Health Care Equipment and Supplies
Category
N/A
First Eagle Global Fund Portfolio Holding: Becton, Dickinson and Company
BDX (holding update): Q4 revenue miss from weak research instruments & diagnostics due to lower global research spending & tariff impact. Despite headwinds, strong cash generation continues with shareholder returns via buybacks & dividends. Medical device diversification provides resilience.
Read full article (1 min)